drugset / Trial / NCT06164600

Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children

NCT06164600 ↗

Phase 2 Completed 60 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Prebiotics as bovine colostrum are considered as a valuable supplement in the prevention of upper respiratory tract infections, gastrointestinal tract infections and neonatal sepsis. It contains many bioactive substances, such as immunoglobulins, lactoferrin, lysozyme, lactoperoxidase, and other growth factors.There is a lack of research on the use of prebiotics for prophylaxis against recurrent urinary tract infection (UTI) in children.In this era of increasing bacterial resistance to antimicrobial therapy, bovine colostrum can offer an approach for prophylaxis against UTI in these patients.We aim at this trial to evaluate the efficacy and safety of bovine colostrum as a prebiotic for prophylaxis against recurrent urinary tract infection in children.

Timeline

Start
2023-06-01
Primary completion
2024-08-20
Completion
2024-08-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bovine Colostrum Protein / enzyme biologic 1 unknown —
Subject Bovine Colostrum Protein / enzyme biologic 2 unknown —